The Alliance of Community Health Plans (ACHP) submitted a letter to the Centers for Medicare & Medicaid Services (CMS) about the National Coverage Determination (NCD) for beta amyloid pet scans in dementia and neurodegenerative disease patients.
With promising but uncertain treatments of Alzheimer’s actively in development, testing and early usage, now is not the appropriate time to change an NCD that has been in place and working since 2013.
New from ACHP:
- ACHP Letter to CMS on Proposed CY 2026 Policy and Technical Changes
- ACHP Letter to National Association of Medicaid Directors
- ACHP Statement on 2027 Medicare Drug Negotiations
- ACHP Statement on CY2026 Medicare Advantage and Part D Rate Notice
- ACHP Letter to Trump HHS Transition Team
- ACHP Joins Hospital-at-Home Sign-On Letter to Congress